These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 24144916)
1. Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts. He ZY; Wei XW; Luo M; Luo ST; Yang Y; Yu YY; Chen Y; Ma CC; Liang X; Guo FC; Ye TH; Shi HS; Shen GB; Wang W; Gong FM; He G; Yang L; Zhao X; Song XR; Wei YQ J Control Release; 2013 Dec; 172(3):679-89. PubMed ID: 24144916 [TBL] [Abstract][Full Text] [Related]
2. Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3. Sun C; Yi T; Song X; Li S; Qi X; Chen X; Lin H; He X; Li Z; Wei Y; Zhao X Oncol Rep; 2011 Jul; 26(1):193-200. PubMed ID: 21519794 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer. Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex. He ZY; Deng F; Wei XW; Ma CC; Luo M; Zhang P; Sang YX; Liang X; Liu L; Qin HX; Shen YL; Liu T; Liu YT; Wang W; Wen YJ; Zhao X; Zhang XN; Qian ZY; Wei YQ Sci Rep; 2016 Mar; 6():23764. PubMed ID: 27026065 [TBL] [Abstract][Full Text] [Related]
5. VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice. Bai Y; Deng H; Yang Y; Zhao X; Wei Y; Xie G; Li Z; Chen X; Chen L; Wang Y; Su D; Qian Z; Zhong Q; Luo H; Yi T Oncology; 2009; 77(6):385-94. PubMed ID: 20130421 [TBL] [Abstract][Full Text] [Related]
6. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651 [TBL] [Abstract][Full Text] [Related]
7. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Huang YH; Bao Y; Peng W; Goldberg M; Love K; Bumcrot DA; Cole G; Langer R; Anderson DG; Sawicki JA Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3426-30. PubMed ID: 19208807 [TBL] [Abstract][Full Text] [Related]
8. Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy. Luo M; Liang X; Luo ST; Wei XW; Liu T; Ren J; Ma CC; Yang YH; Wang BL; Liu L; Song XR; He ZY; Wei YQ J Biomed Nanotechnol; 2015 Nov; 11(11):2011-23. PubMed ID: 26554159 [TBL] [Abstract][Full Text] [Related]
9. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells]. Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458 [TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo. Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T Oncology; 2009; 77(1):22-32. PubMed ID: 19440000 [TBL] [Abstract][Full Text] [Related]
11. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1. Shang X; Lin X; Manorek G; Howell SB Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666 [TBL] [Abstract][Full Text] [Related]
12. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer. Zou L; Song X; Yi T; Li S; Deng H; Chen X; Li Z; Bai Y; Zhong Q; Wei Y; Zhao X Cancer Gene Ther; 2013 Apr; 20(4):242-50. PubMed ID: 23492823 [TBL] [Abstract][Full Text] [Related]
13. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA. Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703 [TBL] [Abstract][Full Text] [Related]
14. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
15. Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha. He Z; Yu Y; Zhang Y; Yan Y; Zheng Y; He J; Xie Y; He G; Wei Y; Song X J Biomed Nanotechnol; 2013 May; 9(5):833-44. PubMed ID: 23802413 [TBL] [Abstract][Full Text] [Related]
16. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells]. Liu YL; Zheng JH Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927 [TBL] [Abstract][Full Text] [Related]
17. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells. Luo Y; Yi Y; Yao Z Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010 [TBL] [Abstract][Full Text] [Related]
18. [Effect of reduced expression of Her2 by RNA interference on the biological characters of ovarian carcinoma cells]. Wang KF; Cui H; Feng J; Yang R; Liang XD; Chang XH; Li Y; Cheng YX; Cheng HY; Ye X Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):622-5. PubMed ID: 19087501 [TBL] [Abstract][Full Text] [Related]
19. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results. Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876 [TBL] [Abstract][Full Text] [Related]
20. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells. Tong L; Chen W; Wu J; Li H Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]